Early-stage gastric MALT lymphoma: Is it a truly localized disease?

Oncologist

Volumn 14, Issue 2, 2009, Pages 148-154

  Siakantaris, Marina P ^a,c   Pangalis, Gerassimos A ^a   Dimitriadou, Evangelia ^a   Kontopidou, Flora N ^a   Vassilakopoulos, Theodoros P ^a   Kalpadakis, Christina ^a   Sachanas, Sotirios ^a   Yiakoumis, Xanthi ^a   Korkolopoulou, Penelope ^b   Kyrtsonis, Marie Christine ^a   Bobotsis, Panayia ^a   Androulaki, Athina ^b   Patsouris, Eustratios ^b   Panayiotidis, Panayiotis ^a   Angelopoulou, Maria K ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

MALT lymphoma; Monoclonality; Occult disease; VH genes

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OCCULT BLOOD; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH LYMPHOMA; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; FEMALE; HELICOBACTER INFECTIONS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 64149083444     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0178     Document Type: Article

References (58)

1. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin He-matol 1999;36:139-147.
2. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lym-phoma and low-grade B-cell mucosa-associated lymphoid tissue lym-phoma (MALToma) of the stomach. Am J Pathol 1990;136:1153-1164.
3. Zucca E, Bertoni F, Roggero E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. NEnglJMed 1998;338:804-810.
4. Guindi M. Role of Helicobacter pylori in the pathogenesis of gastric carcinoma and progression of lymphoid nodules to lymphoma. Can J Gastroen-terol 1999;13:224-227.
5. Calvert R, Randerson J, Evans P et al. Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet 1995;345:26-27.
6. Fischbach W, Goebeler-Kolve ME, Dragosics B et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter /pylori eradication therapy: Experience fromalarge prospectiveseries. Gut2004;53:34-37.
7. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
8. Liu H, Ye H, Ruskone-Fourmestraux A et al. t(11;18) is a marker for all stage gastric malt lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-1294.
9. DierlammJ, BaensM, WlodarskaIet al. TheapoptosisinhibitorgeneAPI2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21; q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-3609.
10. DierlammJ, MurgaPenasEM, DaibataMet al. Thenovelt(11;12:18)(q21;q13;q21) represents a variant translocation ofthe t(11;18)(q21;q21) associated with MALT-type lymphoma. Leukemia 2002;16:1863-1864.
11. Thieblemont C, Berger F, Dumontet C et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000;95:802-806.
12. Lambrechts AC, Hupkes PE, Dorssers LC et al. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 1993; 82:2510-2516.
13. PriceCG, MeerabuxJ, MurtaghS et al. Thesignificanceofcirculatingcells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991;9:1527-1532.
14. Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment:What has changed over the past 10 years? Br J Haematol 2007;136:521-538.
15. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: A review with special emphasis on diagnostic and management problems of low-grade gastric tumours. BrJ Haematol 1998;100:3-14.
16. Hanson CA, Kurtin PJ, Katzmann JA et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lym-phoma. Blood 1999;94:3889-3896.
17. Height SE, Swansbury GJ, Matutes E et al. Analysis of clonal rearrangements ofthe Ig heavy chain locus in acute leukemia. Blood 1996;87:5242-5250.
18. Wan JH, Trainor KJ, Brisco MJ et al. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888-890.
19. Macintyre EA, Delabesse E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999;36:373-389.
20. Raplen R. PCR Sequencing Protocols. Totowa, NJ: Humana Press, 1996:1221.
21. Ghia P, Stamatopoulos K, Belessi C et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.Leukemia 2007;21: 1-3.
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. JAm Stat Assoc 1958;53:457-481.
23. Lossos IS, Tibshirani R, Narasimhan B et al. The inference of antigen selection on Ig genes. J Immunol 2000;165:5122-5126.
24. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 2007;56:772-781.
25. O'Morain C, Borody T, Farley A et al. Efficacy and safety of single-triple capsules of bismuth biskalcitrate metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: An international multicentre study. Aliment Pharmacol Ther 2003;17:415-420.
26. Neubauer A, Thiede C, Morgner A et al. Cure of Helicobacter pylori infection and duration ofremissionoflow-grade gastricmucosa-associated lym-phoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-1355.
27. Isaacson PG, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984;53:2515-2524.
28. Nathwani BN, Anderson JR, Armitage JO et al. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999;17:2486-2492.
29. Kalpadakis C, Pangalis GA, Vassilakopoulos TP et al. Non-gastric extra-nodal marginal zone lymphomas-a single centre experience on 76 patients. Leuk Lymphoma 2008;49:2308-2315.
30. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: A clinicopathological study of 145 patients. Gastroenterology 1991;101:1159-1170.
31. Nardini E, Rizzi S, Ménard S et al. Molecular phenotype distinguishes two subsets of gastric low-grade mucosa-associated lymphoid tissue lymphomas. Lab Invest 2002;82:535-541.
32. Raderer M, Vorbeck F, Formanek M et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lym-phoma. Br J Cancer 2000;83:454-457.
33. Thieblemont C, Bastion Y, Berger F et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients. J Clin Oncol 1997;15:1624-1630.
34. Gribben JG, Freedman A, Woo SD et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991;78:3275-3280.
35. chel JM, Zucker ML, Fox CM et al. Monoclonal B-cell lymphocytosis in lood donors. Br J Haematol 2007;139:832-836.
36. ertoni F, Gisi M, Roggero E et al. Molecular detection of circulating neoplastic cells in patients with clinically localised gastric and non-gastric mucosa-associated lymphoid tissue lymphoma. Dig Liver Dis 2000;32:188-191.
37. Griesser H, Kaiser U, Augener W et al. B-cell lymphoma of the mucosa-associated lymphatic tissue (MALT) presenting with bone marrow and peripheral blood involvement. Leuk Res 1990;14:617-622.
38. Du MQ, Peng HZ, Dogan A et al. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone. Blood 1997;90:4071-4077.
39. Bertoni F, SannaP, Tinguely M et al. Association of gastric and Waldeyer's ring lymphoma: A molecular study. Hematol Oncol 2000;18:15-19.
40. Graziadei G, Pruneri G, Carboni N et al. Low-grade MALT lymphoma involving multiple mucosal sites and bone marrow. Ann Hematol 1998;76:81-83.
41. Siakantaris MP, Gonis NK, Angelopoulou MK et al. Low grade gastric MALT lymphoma (LGGMALT) clinical stage I. A seemingly localized disease. Blood 2000:96(suppl 1):329a.
42. Siakantaris MP, Angelopoulou MK, Vassilakopoulos TP et al. Marginal zone non-Hodgkin's lymphomas ofthe MALT type. Haema 2006;9S:117-120.
43. Du MQ, Diss TC, Dogan A et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol 2000;192: 488-493.
44. Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 1999;36:178-197.
45. Briskin M, Winsor-Hines D, Shyjan A et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
46. Dogan A, Du M, Koulis A et al. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997;151:1361-1369.
47. Farstad IN, Halstensen TS, Kvale D et al. Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoma tissue: Relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes. Am J Pathol 1997;150:187-199.
48. 1 integral, peripheral node addressin/l-selectin, and lymphocyte function-associated antigen-1 adhesionpathways. AmJPathol2001;159:671-681.
49. Sakuma H, Nakamura T, Uemura N et al. Immunoglobulin VH gene analysis in gastric MALT lymphomas. Mod Pathol 2007;204:460-466.
50. Du M, Diss TC, Xu C et al. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996;10:1190-1197.
51. Kp̈pers R, Klein U, Hansmann ML et al. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-1529.
52. Bende RJ, Aarts WM, Riedl RG et al. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005;201:1229-1241.
53. Bertoni F, Cazzaniga G, Bosshard G et al. Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol 1997;97:830-836.
54. Dierlamm J, Wlodarska I, Michaux L et al. Genetic abnormalities in marginal zone B-cell lymphoma. Hematol Oncol 2000;18:1-13.
55. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB et al. The role of clonal selection and somatic mutationin autoimmunity. Nature 1987;328:805-811.
56. Yin CC, Medeiros LJ, Cromwell CC et al. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 2007;20:1-7.
57. Martinelli G, Laszlo D, Ferreri AJ et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005;23:1979-1983.
58. Conconi A, MartinelliG, ThieblemontC et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102: 2741-2745.